2010
DOI: 10.1179/016164109x12464612122731
|View full text |Cite
|
Sign up to set email alerts
|

Effect of COX-2 inhibitor meloxicam against traumatic brain injury-induced biochemical, histopathological changes and blood–brain barrier permeability

Abstract: Meloxicam exerts neuroprotective effect by preserving BBB permeability and by reducing brain edema (probably by its anti-inflammatory properties) in the diffuse brain injury model.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
36
0
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 49 publications
(38 citation statements)
references
References 35 publications
1
36
0
1
Order By: Relevance
“…They showed that the immune reaction peaks between 24-72 hours after injury and the neuroprotective effect of treatment with COX-2 inhibitors begins 6 hours after injury (7). Various researchers have observed increased motor performance after neurotrauma and ischemia with COX-2 inhibitors in animal models (5,8). In our study, animals were sacrificed 24 hours after trauma, which allowed time for the effects of COX-2 inhibition to occur.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…They showed that the immune reaction peaks between 24-72 hours after injury and the neuroprotective effect of treatment with COX-2 inhibitors begins 6 hours after injury (7). Various researchers have observed increased motor performance after neurotrauma and ischemia with COX-2 inhibitors in animal models (5,8). In our study, animals were sacrificed 24 hours after trauma, which allowed time for the effects of COX-2 inhibition to occur.…”
Section: Discussionmentioning
confidence: 99%
“…In our study, the higher levels of superoxide dismutase activity induced by TBI decreased with lornoxicam treatment. Other COX-2 inhibitors besides lornoxicam have also been reported to have antioxidant effects, in addition to their anti-inflammatory actions (2,8).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…[11] Meloxicam, a COX-2 inhibitor, has been found to preserve BBB permeability, decrease anti-inflammatory activity, and decrease brain edema in a model of diffuse TBI. [21] The central nervous system inflammatory reaction occurring after aneurysmal subarachnoid hemorrhage and intracerebral hemorrhage involves the upregulation of numerous cytokines and prostaglandins. [22,23] After intracerebral hemorrhage, COX inhibition with celecoxib, a selective COX-2 inhibitor, decreases brain edema, inflammation, and perihematomal cell death by decreasing generation of prostaglandin E2.…”
Section: Discussionmentioning
confidence: 99%
“…To evaluate the blood-brain barrier integrity, Evans blue (EB) dye was used as a marker of albumin extravasation (22). EB was expressed as μg/mg of brain tissue against a standard curve…”
Section: Evans Blue Assay For Blood˗brain Barrier Permeabilitymentioning
confidence: 99%